Trent Carrier
Direttore operativo presso L7 Informatics, Inc.
Profilo
Trent Carrier is associated with multiple firms in the biotech industry.
He is currently the Chief Executive Officer and Director at CytoSen Therapeutics, Inc., Executive Director-Business Strategy at Biologics Consulting Group, Inc., Director at NERx Biosciences, Inc., and Chief Operating Officer at L7 Informatics, Inc.
Posizioni attive di Trent Carrier
| Società | Posizione | Inizio |
|---|---|---|
Biologics Consulting Group, Inc.
 Biologics Consulting Group, Inc. Miscellaneous Commercial ServicesCommercial Services Biologics Consulting Group, Inc. provides regulatory and product development advisory services for drugs and device products. It specializes in the preparation and review of CBER, CDER and CDRH regulatory applications, facility inspection, process validation packages, and electronic submissions. The company was founded by James G. Kenimer in 1993 and is headquartered in Alexandria, VA. | Corporate Officer/Principal | 12/08/2011 |
L7 Informatics, Inc.
 L7 Informatics, Inc. Packaged SoftwareTechnology Services L7 Informatics, Inc. provides integrated informatics platform for laboratory operations. The firm''s solutions include EnterpriseScience Platform, Genomic Cloud, BioBuilds and custom solutions. The company was founded by Christopher Mueller in 2011 and is headquartered in Austin, TX. | Direttore operativo | 01/10/2019 |
NERx Biosciences, Inc.
 NERx Biosciences, Inc. BiotechnologyHealth Technology NERx Biosciences, Inc. engages in the discovery and development of targeted therapeutics for cancer. The firm specializes in early development of novel biopharmaceutical compounds. It focuses on new generation of cancer drugs that target specific cellular processes not currently being exploited as cancer therapies. The company was founded by John Turchi and Robert Feltgen in 2009 and is headquartered in Indianapolis, IN. | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Trent Carrier
| Società | Posizione | Fine |
|---|---|---|
CytoSen Therapeutics, Inc.
 CytoSen Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services CytoSen Therapeutics, Inc. develops natural killer (NK) cell therapeutics for cancer. It offers nanoparticle processing technology which enables improved ex vivo expansion and activation of NK-cells supporting multiple high dose infusions with anti-cancer cytotoxicity. The company was founded by Stefan O. Ciurea, Dean Lee and Robert Igarashi and is headquartered in Orlando, FL. | Amministratore Delegato | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 4 |
|---|---|
Biologics Consulting Group, Inc.
Biologics Consulting Group, Inc. Miscellaneous Commercial ServicesCommercial Services Biologics Consulting Group, Inc. provides regulatory and product development advisory services for drugs and device products. It specializes in the preparation and review of CBER, CDER and CDRH regulatory applications, facility inspection, process validation packages, and electronic submissions. The company was founded by James G. Kenimer in 1993 and is headquartered in Alexandria, VA. | Commercial Services |
CytoSen Therapeutics, Inc.
CytoSen Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services CytoSen Therapeutics, Inc. develops natural killer (NK) cell therapeutics for cancer. It offers nanoparticle processing technology which enables improved ex vivo expansion and activation of NK-cells supporting multiple high dose infusions with anti-cancer cytotoxicity. The company was founded by Stefan O. Ciurea, Dean Lee and Robert Igarashi and is headquartered in Orlando, FL. | Commercial Services |
L7 Informatics, Inc.
L7 Informatics, Inc. Packaged SoftwareTechnology Services L7 Informatics, Inc. provides integrated informatics platform for laboratory operations. The firm''s solutions include EnterpriseScience Platform, Genomic Cloud, BioBuilds and custom solutions. The company was founded by Christopher Mueller in 2011 and is headquartered in Austin, TX. | Technology Services |
NERx Biosciences, Inc.
NERx Biosciences, Inc. BiotechnologyHealth Technology NERx Biosciences, Inc. engages in the discovery and development of targeted therapeutics for cancer. The firm specializes in early development of novel biopharmaceutical compounds. It focuses on new generation of cancer drugs that target specific cellular processes not currently being exploited as cancer therapies. The company was founded by John Turchi and Robert Feltgen in 2009 and is headquartered in Indianapolis, IN. | Health Technology |
- Borsa valori
- Insiders
- Trent Carrier
